argenx SE
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ARGX | ROIV | 9995.HK | 095700.KQ | 6IB.F | 688520.SS | |
|---|---|---|---|---|---|---|
| Market cap | 58.57B | 27.61B | 40.23B | 94.14B | 17.27B | 15.35B |
| P/E (TTM) | 32.3 | — | 6.1 | — | 123.8 | — |
| Forward P/E | 28.0 | -27.5 | 46.7 | — | — | 21.9 |
| Price/book | 173.0 | 6.5 | 3.8 | — | 6.2 | -22.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +9.44% | +85.85% | −19.94% | −60.56% | −1.76% | −37.00% |
| Today | +3.36% | +6.08% | +1.49% | +0.73% | +3.42% | +1.02% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All ARGX news ›INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
FinancialContent INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on b
argenx to Present at Upcoming Investor Conferences
The Manila Times Amsterdam, the Netherlands - argenx (Euronext & Nasdaq: ARGX), the immunology innovation company, today announced that members of the management team will participate in the following investor conferences in November: -…
argenx to present at two major healthcare investor conferences in November 2026
argenx, an immunology innovation company, announced its management team will participate in two investor conferences in November 2026: the Guggenheim Healthcare Innovation Conference in Boston on November 10 and the Jefferies London Global…
Arvinas presents data from clinical trial of ARV-102
Arvinas (ARVN) presented novel data from a Phase 1 clinical trial of ARV-102, an investigational PROteolysis TArgeting Chimera, or PROTAC, degra... Arvinas presents data from clinical trial of ARV-102 Arvinas (ARVN) presented novel data…
Analysts Have Conflicting Sentiments on These Healthcare Companies: Molina Healthcare (MOH), Quest Diagnostics (DGX) and Argenx Se (ARGX)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Molina Healthcare (MOH), Quest Diagnostics (DGX) and Argenx Se (ARGX). In a report released today, Andrew Mok CFA from Barclays maintained a…
Ianalumab Lowers Disease Activity in Sjögren’s Disease, Though Symptom Benefits Remain Unclear
Monthly ianalumab reduced systemic disease activity in Sjögren’s disease, but symptom improvements remained limited. Ianalumab Lowers Disease Activity in Sjögren’s Disease, Though Symptom Benefits Remain Unclear Patients with active…
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
Chicago, IL – October 16, 2026– Today, Zacks Investment Ideas feature highlights Cummins CMI, Argenx ARGX and PACCAR PCAR. AI stocks sold off Wednesday and in early morning trading Thursday as investors raced to protect profits. That said,…
argenx's Forte acquisition delivers coeliac trial win
argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2 billion acquisition of Forte Biosciences, will move into phase 3 development for coeliac disease after showing efficacy in a mid-stage trial. There are no FDA-approved…
argenx Q3 2026: $1.72B Revenue and Five 2027 Launches Ahead
As seen on the 24/7 Wall St. homepage on October 22, 2026. As many as five new launches are lined up for 2027, spanning pediatric gMG, ocular MG, necrotizing myopathy, the autoinjector and empasiprubart in MMN, on the back of VYVGART…
argenx Reports Third Quarter 2026 Financial Results and Provides Business Update
Continued strong VYVGART performance drives $1.7 billion in global product net sales, representing 54% year-over-year growth and 13% quarter-over-quarter growth sBLA for VYVGART Hytrulo in IMNM on track for submission by year-end; pursuing…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- theglobeandmail.com9
- seekingalpha.com5
- stocktitan.net5
- tradingview.com5
- manilatimes.net3
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 69 articles, not a forecast.